Munich - Delayed Quote EUR
Mersana Therapeutics Inc (0M4.MU)
0.3306
+0.0138
+(4.36%)
At close: May 15 at 8:00:15 AM GMT+2
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
0M4.MU | -- | -- | -- | -- |
S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
Initiated | William Blair: Outperform | 2/6/2025 |
Maintains | Citigroup: Buy to Buy | 8/27/2024 |
Maintains | Baird: Neutral to Neutral | 8/14/2024 |
Upgrade | JP Morgan: Underweight to Neutral | 3/19/2024 |
Upgrade | Wedbush: Neutral to Outperform | 2/29/2024 |
Upgrade | Truist Securities: Hold to Buy | 2/29/2024 |
Related Tickers
IGC IGC Pharma, Inc.
0.2922
+0.55%
AZTR Azitra, Inc.
0.2805
+0.86%
ELEV Elevation Oncology, Inc.
0.2998
-12.24%
CYCC Cyclacel Pharmaceuticals, Inc.
2.2000
-5.17%
SPRY ARS Pharmaceuticals, Inc.
12.20
+0.79%
ABSI Absci Corporation
2.9600
+1.72%
HUMA Humacyte, Inc.
1.8900
+1.07%
RXRX Recursion Pharmaceuticals, Inc.
4.2500
-1.39%
CRSP CRISPR Therapeutics AG
36.31
+1.99%
NVAX Novavax, Inc.
6.29
+5.54%